CoChat

The potential use of saliva to detect recurrence of disease in women with breast carcinoma

Bigler, Lenora R., Streckfus, Charles F., Copeland, Lynn, Burns, Rebecca, Dai, Xiaoli, Kuhn, Melinda, Martin, Patricia, Bigler, Steven A. · 2002 · Journal of Oral Pathology & Medicine
Cited by 85

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background: Approximately 1 woman in every 10 will develop breast cancer in her lifetime. It has been shown that screening for breast cancer can reduce breast cancer mortality. The use of a saliva‐based test could prove to be very useful in post‐operative and/or adjunctive therapy management of breast cancer patients. Methods: The following study was undertaken to establish the possible usefulness of the salivary protein product of the oncogene c‐erbB‐2 in following patients diagnosed with carcinoma of the breast. Included in this study were 25 patients with a mean age of 54 years with varying histological diagnoses and stages of carcinoma of the breast. ELISA assays for c‐erb B‐2 and CA 15–3 were performed on serum and stimulated whole saliva samples collected on all patients prior to any adjunct therapy or surgery and sequentially during therapy. Results: The results of the GLM analyses using marker concentration as the dependent variable and treatment regimen and the serial assessments as independent variables yielded a significant overall model for both the serum (P < 0.007) and salivary (P < 0.017) c‐erb B‐2 markers. The model for serum c‐erb B‐2, however, exhibited a significant difference for treatment regimen (P < 0.001) with the chemotherapy and radiation treatment regimen being significantly different (P < 0.001) from the other treatment therapies. Time (serial assessments) was not significant. The model for the salivary c‐erb B‐2 marker was reversed. Treatment regimen was not significant for this model; however, time (serial assessments) was significant (P < 0.002). The serum and salivary CA 15–3 marker models yielded no significant results. Paired t‐test analyses indicated that only the salivary c‐erb B‐2 concentrations exhibited a significant difference between the pre‐ and post‐therapy values (t = 4.245, P < 0.0001). Additionally, salivary c‐erbB‐2 displayed greater percent reductions across all therapies as compared to the other markers. Conclusions: This preliminary study appears to indicate that c‐erb B‐2 protein expression in saliva may be a very useful diagnostic tool for measuring patient response to chemotherapy and/or surgical treatment of their disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1034/j.1600-0714.2002.00123.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 85

Metadata

Authors
Bigler, L. R., Streckfus, C. F., Copeland, L., Burns, R., Dai, X., Kuhn, M., Martin, P., & Bigler, S. A.
Venue
Journal of Oral Pathology & Medicine
Publisher
Wiley
Published
2002-08
Volume
31
Issue
7
Pages
421-431
ISSN
  • 0300-9777 (ISSN-L)
  • 0904-2512
  • 1600-0714
OpenAlex
W1972026849
Cited by
85
References
1
FWCI
0.82
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The potential use of saliva to detect recurrence of disease in women with breast carcinoma. https://app.cochat.ai/papers/10.1034/j.1600-0714.2002.00123.x
The paper
Bigler, L. R., Streckfus, C. F., Copeland, L., Burns, R., Dai, X., Kuhn, M., Martin, P., & Bigler, S. A. (2002). The potential use of saliva to detect recurrence of disease in women with breast carcinoma. Journal of Oral Pathology & Medicine. https://doi.org/10.1034/j.1600-0714.2002.00123.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.